Przybylski Tomasz, Czerniel Joanna, Dobrosielski Jakub, Stawny Maciej
Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.
Molecules. 2025 Jul 25;30(15):3113. doi: 10.3390/molecules30153113.
Flavonols, representing a subclass of flavonoids, are an important group of polyphenols. Their activity is associated with a number of beneficial properties, including hepatoprotective, senolytic, neuroprotective, and anticancer properties. They are found abundantly in many fruits, vegetables, and plant products, but flavonols' chemistry and structural properties result in their low bioavailability in vivo. In recent years, more and more studies have emerged that aim to increase the therapeutic potential of compounds belonging to this group, including by developing innovative nanoformulations. The present work focuses on the various steps, such as chemical analysis of the compounds, preformulation studies using drug delivery systems, preclinical studies, and finally clinical trials. Each of these elements is important not only for the innovation and efficacy of the therapy but most importantly for the patient's health. There are also a limited number of studies assessing the population concentration of flavonols in the blood; therefore, this review presents an up-to-date survey of the most recent developments, using the most important compounds from the flavonol group.
黄酮醇是黄酮类化合物的一个亚类,是一类重要的多酚。它们的活性与许多有益特性相关,包括肝脏保护、溶酶体清除、神经保护和抗癌特性。它们在许多水果、蔬菜和植物产品中大量存在,但黄酮醇的化学和结构特性导致其在体内的生物利用度较低。近年来,越来越多的研究旨在提高这类化合物的治疗潜力,包括开发创新的纳米制剂。目前的工作集中在各个步骤,如化合物的化学分析、使用药物递送系统的处方前研究、临床前研究以及最后的临床试验。这些要素中的每一个不仅对治疗的创新性和有效性很重要,而且最重要的是对患者的健康很重要。评估血液中黄酮醇在人群中的浓度的研究数量也有限;因此,本综述使用黄酮醇类中最重要的化合物,对最新进展进行了最新的调查。